{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:55:05Z","timestamp":1777694105944,"version":"3.51.4"},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,1,30]],"date-time":"2007-01-30T00:00:00Z","timestamp":1170115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> A hematopoietic stem cell transplant recipient developed a mucosal herpes simplex virus\u20101 (HSV\u20101) infection while under acyclovir (ACV) treatment (HSV was later shown to be resistant to ACV). Concomitantly, the patient presented a hemorrhagic cystitis (HC) due to polyomavirus BK, for which intravenous cidofovir (CDV) was prescribed. The patient benefited from the broad\u2010spectrum anti\u2010DNA virus activity of CDV, and not only the HC resolved without signs of nephrotoxicity but also the HSV\u20101 lesions disappeared. This is the first report describing the effect of CDV on 2 simultaneous and unrelated DNA viral infections in an immunosuppressed transplant recipient. In addition, we describe here that this HSV\u20101 isolate possesses a unique phenotype and genotype.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2006.00186.x","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T18:25:25Z","timestamp":1170440725000},"page":"126-131","source":"Crossref","is-referenced-by-count":25,"title":["Dual infection with polyomavirus BK and acyclovir\u2010resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient"],"prefix":"10.1111","volume":"9","author":[{"given":"G.","family":"Andrei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fiten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Goubau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Van Landuyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gordts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Selleslag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Opdenakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,30]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20567"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(02)00263-9"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/422364"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.1.208-213.2005"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2004.02.007"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-3-639"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/498151"},{"key":"e_1_2_8_9_2","first-page":"928","article-title":"Acyclic nucleoside phosphonates","volume":"4","author":"De Clercq E","year":"2005","journal-title":"a key class of antiviral drugs"},{"key":"e_1_2_8_10_2","first-page":"1561","article-title":"Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients","volume":"3","author":"Snoeck R","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.4.569-596.2003"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701523"},{"key":"e_1_2_8_13_2","first-page":"925","article-title":"Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation","volume":"32","author":"Cesaro S","year":"2003","journal-title":"a survey from the Italian Association of Pediatric Hematology Oncology-Bone Marrow Transplantation Group"},{"key":"e_1_2_8_14_2","first-page":"929","article-title":"Polyoma BK virus and hemorrhagic cystitis in haematopoietic stem cell transplantation","volume":"36","author":"Leung AYH","year":"2005","journal-title":"a changing paradigm"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00980.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.06.007"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.5.1707-1713.2003"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.9.5863-5869.2005"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.606-611.2005"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.4.570"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.4.1761-1769.2001"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702591"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb04735.x"},{"key":"e_1_2_8_24_2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0021-9258(18)52426-1","article-title":"Hus\u2010specific DNA polymerase is the target for the antiviral action of 9\u2010(2\u2010phosphonylmethoxyethyl)adenine","volume":"5","author":"Foster SA","year":"1991","journal-title":"J Biol Chem"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2006.00186.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2006.00186.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T08:17:58Z","timestamp":1696925878000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2006.00186.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,30]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1111\/j.1399-3062.2006.00186.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2006.00186.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,30]]}}}